Abstract
Meningiomas are most common intracranial benign tumors comprising around one third of all intracranial neoplasms, and typically have benign and indolent nature with slow-growing behaviour. Benign meningiomas are slow growing tumors typically following an indolent disease course. Nevertheless, atypical or anaplastic meningiomas may follow a more aggressive disease course with invasion of critical structures and recurrences. In the current study, we evaluate the incorporation of magnetic resonance imaging (MRI) for radiosurgery treatment planning of atypical meningiomas.
Atypical meningioma radiosurgery target volume determination with and without incorporation of MRI has been evaluated. Ground truth target volume used as the reference has been outlined by the board-certified group of radiation oncologists after comprehensive assessment, thorough collaboration and consensus.
Target volume definition by use of Computed Tomography (CT)-only imaging and by CT-MR fusion based imaging has been comparatively evaluated in this study for linear accelerator (LINAC)-based radiosurgical management of atypical meningioma. Ground truth target volume defined by the board-certified radiation oncologists after detailed evaluation, collaboration, colleague peer review and consensus has been found to be identical to target determination by use of CT-MR fusion based imaging.
Despite significant progress in neurosurgical techniques over the years, complete surgical resection may not be feasible in the presence of meningiomas located at eloquent brain areas in close association with important neurovascular structures. RT may have a role in multidisciplinary management of meningiomas. Incorporation of MRI into treatment planning for radiosurgery of atypical meningiomas may improve target definition despite the need for further supporting evidence.
Author Contributions
Copyright© 2020
Demiral Selcuk, et al.
License
This work is licensed under a Creative Commons Attribution 4.0 International License.
This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Competing interests The authors have declared that no competing interests exist.
Funding Interests:
Citation:
Introduction
Meningiomas are most common intracranial benign tumors comprising around one third of all intracranial neoplasms, and typically have benign and indolent nature with slow-growing behaviour Presentation is typically at the 6th to 8th decades of life and incidence increases with increasing age Meningiomas can be located at several locations throughout the CNS, however, supratentorial region is the most frequent location followed by the skull base and posterior fossa Benign meningiomas are slow growing tumors typically following an indolent disease course. Nevertheless, atypical or anaplastic meningiomas may follow a more aggressive disease course with invasion of critical structures and recurrences Magnetic resonance imaging (MRI) constitutes the principal modality for imaging of meningiomas. Nevertheless, computed tomography (CT) imaging may aid in detection of tumoral calcifications, intraosseous growth of the tumor particularly for base of skull lesions, and hyperostosis of the neighboring bone Active surveillance with periodical neuroimaging can be a viable option for incidentally detected and asymptomatic meningiomas Accurate definition of the target volume is an integral part of successful radiosurgery applications given the smaller treatment volumes receiving higher doses per fraction. Radiosurgery treatment planning has been traditionally based on CT-simulation images of the patients acquired at treatment position. In the current study, we evaluate the incorporation of MRI for radiosurgery treatment planning of atypical meningiomas.
Materials And Methods
Atypical meningioma radiosurgery target volume determination with and without incorporation of MRI has been evaluated. Ground truth target volume used as the reference has been outlined by the board-certified group of radiation oncologists after comprehensive assessment, thorough collaboration and consensus. Informed consents have been provided before treatment, and management with radiosurgery has been decided by multidisciplinary collaboration of a team of experts from neuroradiology, neurosurgery, and radiation oncology. Comprehensive evaluation has been performed taking into account the lesion location, size, symptomatology and patient preferences. CT-simulation for radiosurgery treatment planning has been performed at the CT-simulator (GE Lightspeed RT, GE Healthcare, Chalfont St. Giles, UK) available at our department. Planning CT images have been acquired at CT-simulation and these images have been transferred to the contouring workstation (SimMD, GE, UK) for delineation of treatment volumes and critical structures. Target volume definition for radiosurgical management has been performed by use of the CT-simulation images only or fused CT and T1 gadolinium-enhanced MR images. Target definition with CT only and by incorporation of CT-MR fusion has been comparatively assessed. Definition of the ground truth target volume has been performed by board certified radiation oncologists after detailed assessment, colleague peer review, collaboration and consensus to be used for actual treatment and comparison purposes.
Results
Target volume definition by use of CT-only imaging and by CT-MR fusion based imaging has been comparatively evaluated in this study for linear accelerator (LINAC)-based radiosurgical management of atypical meningioma. Ground truth target volume defined by the board-certified radiation oncologists after detailed evaluation, collaboration, colleague peer review and consensus has been found to be identical to target determination by use of CT-MR fusion based imaging. Treatment planning for LINAC-based radiosurgery has been performed by ERGO ++ (CMS, Elekta, UK) radiosurgery planning system. Optimal target coverage and normal tissue sparing has been achieved by using a single 360-degree arc, double 360-degree arcs, or five 180-degree arcs in radiosurgery planning. Synergy (Elekta, UK) LINAC available at our department has been used in delivery of treatment. Delineation of the target volume on planning CT and MR images has been optimized by selecting the appropriate windows and levels for radiosurgery planning. Sagittal and coronal images have been used in addition to the axial planning CT images to achieve accurate contouring of target volume and critical structures. Arc Modulation Optimization Algorithm (AMOA) has been utilized for optimization of target volume coverage and critical organ sparing.
Discussion
Histological subtypes of WHO grade I meningioma are psammomatous meningioma, meningothelial (syncytial) meningioma, transitional (mixed) meningioma, fibroblastic (fibrous) meningioma, secretory meningioma, lymphoplasmacyte-rich meningioma, transitional (mixed) meningioma, microcystic meningioma, and metaplastic meningioma with respect to the WHO classification of Central Nervous System (CNS) tumors Benign meningiomas typically follow an indolent disease course with a low risk of recurrence after complete surgical removal. However, atypical or anaplastic meningiomas may follow a more aggressive disease course with predilection for invasion of critical structures and recurrences despite surgical management There have been substantial advances in the discipline of radiation oncology recently including contemporary treatment strategies such as Image Guided Radiation Therapy (IGRT), Adaptive Radiation Therapy (ART), Intensity Modulated Radiation Therapy (IMRT), Breathing Adapted Radiation Therapy (BART), and stereotactic irradiation with SRS, HFSRT, and SBRT Radiosurgery has been utilized for management of atypical meningiomas with encouraging outcomes In conclusion, incorporation of MRI into treatment planning for radiosurgery of atypical meningiomas may improve target definition despite the need for further supporting evidence.
Cited By (64 articles)
This article has been cited by 64 scholarly works according to:
- OpenAlex: 40 citations
- Crossref: 8 citations
- Semantic Scholar: 23 citations
Citing Articles:
Biomedical Journal of Scientific & Technical Research (2024) openalex
Biomedical Journal of Scientific & Technical Research (2024) openalex
Biomedical Journal of Scientific & Technical Research (2023) openalex
M. Beyzadeoğlu - Biomedical Journal of Scientific & Technical Research (2023) semanticscholar
Biomedical Journal of Scientific & Technical Research (2023) openalex
Cancer therapy & Oncology International Journal (2023) openalex
Biomedical Journal of Scientific & Technical Research (2023) openalex
Biomedical Journal of Scientific & Technical Research (2022) openalex
Biomedical Journal of Scientific & Technical Research (2022) openalex
Biomedical Journal of Scientific & Technical Research (2022) openalex
Biomedical Journal of Scientific & Technical Research (2022) openalex
Cancer therapy & Oncology International Journal (2022) openalex
Cancer therapy & Oncology International Journal (2022) openalex
Cancer therapy & Oncology International Journal (2022) openalex
Cancer therapy & Oncology International Journal (2022) openalex
Cancer therapy & Oncology International Journal (2022) openalex
Journal of Surgery and Surgical Research (2022) openalex
Journal of Surgery and Surgical Research (2022) crossref
Cancer therapy & Oncology International Journal (2022) openalex
Cancer therapy & Oncology International Journal (2022) openalex
Cancer therapy & Oncology International Journal (2021) openalex
Journal of Surgery and Surgical Research (2021) openalex
Journal of Surgery and Surgical Research (2021) openalex
Sager Omer, D. Selcuk, Dincoglan Ferrat, Beyzadeoglu Murat - Journal of Surgery and Surgical Research (2021) semanticscholar
Journal of Surgery and Surgical Research (2021) crossref
Global Journal of Cancer Therapy (2021) openalex
O. Sager, F. Dinçoğlan, S. Demiral, M. Beyzadeoğlu - (2021) semanticscholar
Global Journal of Cancer Therapy (2021) crossref
Biomedical Journal of Scientific & Technical Research (2021) openalex
F. Dinçoğlan - Biomedical Journal of Scientific & Technical Research (2021) semanticscholar
Biomedical Journal of Scientific & Technical Research (2021) openalex
F. Dinçoğlan, O. Sager, S. Demiral, M. Beyzadeoğlu - Biomedical Journal of Scientific & Technical Research (2021) semanticscholar
S. Demiral, F. Dinçoğlan, O. Sager, M. Beyzadeoğlu - ARC Journal of Cancer Science (2021) semanticscholar
O. Sager, S. Demiral, F. Dinçoğlan, M. Beyzadeoğlu - (2021) semanticscholar
International Journal of Research Studies in Medical and Health Sciences (2021) openalex
O. Sager, F. Dinçoğlan, S. Demiral, B. Uysal, H. Gamsız et al. - (2021) semanticscholar
Journal of Surgery and Surgical Research (2021) openalex
Journal of Surgery and Surgical Research (2021) openalex
Sager Omer, Dincoglan Ferrat, D. Selcuk, Beyzadeoglu Murat - Journal of Surgery and Surgical Research (2021) semanticscholar
Journal of Surgery and Surgical Research (2021) crossref
Biomedical Journal of Scientific & Technical Research (2021) openalex
S. Demiral - Biomedical Journal of Scientific & Technical Research (2021) semanticscholar
ARC Journal of Cancer Science (2021) openalex
Article, FerratDincoglan, O. Sager, S. Demiral, M. Beyzadeoğlu - ARC Journal of Cancer Science (2021) semanticscholar
Journal of Surgery and Surgical Research (2021) openalex
D. Selcuk, Dincoglan Ferrat, Sager Omer, Beyzadeoglu Murat - (2021) semanticscholar
Journal of Surgery and Surgical Research (2021) crossref
Journal of Surgery and Surgical Research (2020) openalex
O. Sager, M. Beyzadeoğlu, F. Dinçoğlan, S. Demiral, B. Uysal et al. - (2020) semanticscholar
Journal of Surgery and Surgical Research (2020) crossref
Cancer therapy & Oncology International Journal (2020) openalex
O. Sager - Cancer therapy & Oncology International Journal (2020) semanticscholar
ARC Journal of Cancer Science (2020) openalex
F. Dinçoğlan, M. Beyzadeoğlu, S. Demiral, O. Sager - (2020) semanticscholar
Biomedical Journal of Scientific & Technical Research (2020) openalex
Asian Journal of Pharmacy Nursing and Medical Sciences (2020) openalex
M. Beyzadeoğlu, F. Dinçoğlan, O. Sager, S. Demiral - (2020) semanticscholar
Journal of Surgery and Surgical Research (2020) openalex
O. Sager, M. Beyzadeoğlu, F. Dinçoğlan, S. Demiral, B. Uysal et al. - (2020) semanticscholar
Journal of Surgery and Surgical Research (2020) crossref
ARC Journal of Cancer Science (2020) openalex
O. Sager, F. Dinçoğlan, S. Demiral, M. Beyzadeoğlu - (2020) semanticscholar
S. Demiral, M. Beyzadeoğlu, O. Sager, FerratDincoglan, B. Uysal et al. - Biomedical Journal of Scientific & Technical Research (2020) semanticscholar
Biomedical Journal of Scientific & Technical Research (2020) openalex
S. Demiral, M. Beyzadeoğlu, F. Dinçoğlan, O. Sager, H. Gamsız et al. - Biomedical Journal of Scientific & Technical Research (2020) semanticscholar
Journal of Surgery and Surgical Research (2020) openalex
Journal of Surgery and Surgical Research (2020) crossref
Beyzadeoglu Murat, Sager Omer, Dincoglan Ferrat, D. Selcuk, Uysal Bora et al. - Journal of Surgery and Surgical Research (2020) semanticscholar
Biomedical Journal of Scientific & Technical Research (2020) openalex
F. Dinçoğlan, M. Beyzadeoğlu, O. Sager, S. Demiral, H. Gamsız et al. - Biomedical Journal of Scientific & Technical Research (2020) semanticscholar
O. Sager, F. Dinçoğlan, S. Demiral, M. Beyzadeoğlu - ARC Journal of Cancer Science (2020) semanticscholar